Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT002933453-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaTreatment